The Gray Zone of Melanocytic Tumors - A Clinical Point of View
Keywords:
Melanocytic lesions, melanoma, dysplastic nevus, dermato-oncologyReferences
Ho J, Collie CJ. What's new in dermatopathology 2023: WHO 5th edition updates. J Pathol Transl Med. 2023 Nov;57(6):337-340.
Clark WH Jr, Ackerman AB. An exchange of views regarding the dysplastic nevus controversy. Semin Dermatol. 1989 Dec;8(4):229-50. PMID: 2701712.
Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047. PMID: 22703915; PMCID: PMC3625372.
Clark WH, Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. Origin of familial malignant melanomas from heritable melanocytic lesions ‘The B-K mole syndrome’ Arch Dermatol. 1978
Cymerman RM, Shao Y, Wang K, et al. De novo vs nevus-associated melanomas: differences in association with prognostic indicators and survival. J Natl Cancer Inst. 2016;108(10):djw121
Pampena R, Kyrgidis A, Lallas A, Moscarella E, Argenziano G, Longo C. A meta-analysis of nevus-associated melanoma: prevalence and practical implications. J Am Acad Dermatol. 2017;77(5):938–945.e4.
Lin WM, Luo S, Muzikansky A, et al. Outcome of patients with de novo versus nevus-associated melanoma. J Am Acad Dermatol. 2015;72(1):54–58.
Published
Issue
Section
License
Copyright (c) 2024 Camila Scharf, Giulia Briatico, Gabriella Brancaccio, Elvira Moscarella, Andrea Ronchi, Giuseppe Argenziano
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
